QNL
- 产品代码
- QNL
- 器械名称
- Medium-Term Adjunctive Predictive Cardiovascular Indicator
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 870.2210
- FDA 专业组
- Cardiovascular
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 5 件
FDA 分类定义
The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events within a defined medium-term period. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
该代码近三年的 510(k)(3 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K233253 | 2024-06-21 | Agilemd, Inc. | eCARTv5 Clinical Deterioration Suite (eCART) | |
| K233216 | 2024-01-13 | Clew Medical , Ltd. | CLEWICU System | |
| K230842 | 2023-10-25 | Implicity, Inc. | SignalHF (IM008) |
FDA 官方分类页: QNL
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。